Another group suggested that metformin might overcome tamoxifen resistance by inhibiting the expression and signaling of receptor tyrosine kinases HER2 and HER3 in tamoxifen-resistant BC cells [37]. The gene discussed is ERBB2; the disease is breast cancer.